Gastric motility normalizers on hot competition.

Published: 2002-02-15 07:00:00

Updated: 2002-02-15 07:00:00

Levosulpiride preparations rapidly substituted for cisapride preparations, a leading gastric motility normalizer, because of its market suspension, triggering a hot competition in the markets.

Janssen Korea's Prepulsid, a gastric motility normalizer drug, once enjoyed its market by keeping the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK